Issue

Vol. 64 No. 11: Issue 11

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Effect of hesperetin on inflammatory and oxidative status in trinitrobenzene sulfonic acid-induced experimental colitis model

https://doi.org/10.14715/cmb/2018.64.11.11
Fatin Rustu Polat
Tekirdag Namik Kemal University Medical Faculty, Department of Surgery, Tekirdag, Turkey
Ihsan Karaboga
Tekirdag Namik Kemal University, School of Health, Tekirdag, Turkey
Muhammed Semih Polat
Istanbul University, Engineering Faculty, Istanbul, Turkey
Zeynep Erboga
Tekirdag Namik Kemal University, Medical Faculty, Department of Histology and Embryology, Tekirdag, Turkey
Ahsen Yilmaz
Tekirdag Namik Kemal University, Medical Faculty, Department of Histology and Embryology, Tekirdag, Turkey
Savas Güzel
Tekirdag Namik Kemal University, Medical Faculty, Department of Medical Biochemistry, Tekirdag, Turkey

Corresponding Author(s) : Fatin Rustu Polat

polat22@hotmail.com

Cellular and Molecular Biology, Vol. 64 No. 11: Issue 11

Abstract

In our study, the effect of hesperetin on inflammatory and oxidative status in trinitrobenzene sulfonic acid (TNBS)-induced experimental colitis model was investigated through different methods. Eighteen Wistar albino male rats were divided in to three groups: Group I (Control, n = 8; 1 ml physiological saline), Group II (Colitis, n = 8; 1 ml TNBS), Group III (Hesperetin, n = 8; 1 ml TNBS and 100 mg/kg hesperetin). Macroscopic and microscopic scores were calculated to determine the damage to the colon at the end of the experiment. Serum tumor necrosis factor-α (TNF-α) and tissue interleukin-6 (IL-6) levels were determined using the ELISA method. Myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) levels were investigated spectrophotometrically. The TUNEL method was used for the detection of apoptotic cells in the colon tissue. Inducible nitric oxide synthase (iNOS) and nuclear factor-kappa-B (NF-ĸβ) expression in the colon were determined immunohistochemically. Hesperetin administration has shown to significantly reduce levels of MPO, MDA, and proinflammatory agents (TNF-α, IL-6, and NF-ĸβ). It has also been proven to inhibit mucosal apoptosis. This study indicates that hesperetin is protective against TNBS-induced colitis model via antiinflammatory, antioxidant and antiapoptotic effects.

Keywords

Hesperetin TBNS-induced colitis NF-ĸβ iNOS IL-6 MPO.
Polat, F. R., Karaboga, I., Polat, M. S., Erboga, Z., Yilmaz, A., & Güzel, S. (2018). Effect of hesperetin on inflammatory and oxidative status in trinitrobenzene sulfonic acid-induced experimental colitis model. Cellular and Molecular Biology, 64(11), 58–65. https://doi.org/10.14715/cmb/2018.64.11.11
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Däbritz J, Menheniott TR. Linking immunity, epigenetics, and cancer in inflammatory bowel disease. Inflamm Bowel Dis 2014; 20:1638-1654.
  2. Mazzon E, Muií C, Di Paola R, Genovese T, De Sarro A, Cuzzocrea S. Thalidomide treatment reduces colon injury induced by experimental colitis. Shock 2005; 23:556-564.
  3. Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106:630.
  4. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3:390-407.
  5. Műzes G, Molnár B, Tulassay Z, Sipos F. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol 2012; 18:5848.
  6. Ardizzone S, Porro GB. Biologic therapy for inflammatory bowel disease. Drugs 2005; 65:2253-2286.
  7. Sakthivel K, Guruvayoorappan C. Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-κB signal transduction pathways in rats with ulcerative colitis. Int Immunopharmacol 2013; 17:907-916.
  8. Atreya I, Atreya R, Neurath M. NF-κB in inflammatory bowel disease. J Intern Med 2008; 263:591-596.
  9. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 2007; 52:2015-2021.
  10. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325:1008-1016.
  11. Can G, Ayvaz S, Can H, Karaboğa ć°, Demirtaş S, Akşit H, et al. The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. Clin Res Hepatol Gastroenterol 2016; 40:504-516.
  12. Yuan H, Ji W-S, Wu K-X, Jiao J-X, Sun L-H, Feng Y-T. Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis World J Gastroenterol. 2006; 12:4578.
  13. Soliman GA, Gabr GA, Al-Saikhan FI, Ansari MN, Khan TH, Ganaie MA, et al. Protective effects of two Astragalus species on ulcerative colitis in rats. Trop J Pharm Res 2016; 15:2155-2163.
  14. Tanideh N, Jamshidzadeh A, Saghesloo AG, Rahmanifar F, Mokhtari M, Koohi-Hosseinabadi O, et al. Effects of hydroalcoholic extract of Ziziphus jujuba on acetic acid induced ulcerative colitis in male rat (Rattus norvegicus). J coloproctol (rio j) 2016; 36:189-195.
  15. Bai X, Yang P, Zhou Q, Cai B, Buist"Homan M, Cheng H, et al. The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro. Br J Pharmacol 2017; 174:41-56.
  16. Aranganathan S, Selvam JP, Nalini N. Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen"induced aberrant crypt foci in colon cancer rats: a dose"dependent study. J Pharm Pharmacol 2008; 60:1385-1392.
  17. Di Majo D, Giammanco M, La Guardia M, Tripoli E, Giammanco S, Finotti E. Flavanones in Citrus fruit: Structure–antioxidant activity relationships. Food Res Int 2005; 38:1161-1166.
  18. Kumar M, Dahiya V, Kasala ER, Bodduluru LN, Lahkar M. The renoprotective activity of hesperetin in cisplatin induced nephrotoxicity in rats: Molecular and biochemical evidence. Biomed Pharmacother 2017; 89:1207-1215.
  19. Ren H, Hao J, Liu T, Zhang D, Lv H, Song E, et al. Hesperetin suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 cells via the inhibition of NF-κB and activation of Nrf2/HO-1 pathways. Inflammation 2016; 39:964-973.
  20. Trivedi P, Kushwaha S, Tripathi D, Jena G. Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovasc Toxicol 2011; 11:215-225.
  21. Karaboga ć°, Demirtas S, Karaca T. Investigation of the relationship between the Th17/IL-23 pathway and innate-adaptive immune system in TNBS-induced colitis in rats. Iran J Basic Med Sci 2017; 20:870.
  22. McCAFFERTY D-M, Sharkey KA, Wallace JL. Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol 1994; 266:G560-G567.
  23. Obermeier F, Kojouharoff G, Hans W, Schölmerich J, Gross V, Falk W. Interferon-gamma (IFN-γ)-and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116:238.
  24. Wei H, Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 1991; 51:4443-4449.
  25. Draper H, Hadley M. Malondialdehyde determination as index of lipid Peroxidation Methods Enzymol 1990; 186:421-431.
  26. Durak I, Yurtarslanl Z, Canbolat O, Akyol í–. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 1993; 214:103-104.
  27. Aebi Hi, Bergmeyer H. Methods of enzymatic analysis. Academic Press, New York 1974; 2:674-684.
  28. Shagirtha K, Bashir N, MiltonPrabu S. Neuroprotective efficacy of hesperetin against cadmium induced oxidative stress in the brain of rats. Toxicol Ind Health 2017; 33:454-468.
  29. Yin Y, Xu Y, Ma H, Tian X. Hesperetin ameliorates cardiac inflammation and cardiac fibrosis in streptozotocin-induced diabetic rats by inhibiting NF-kB signaling pathway. Biomed Res 2017; 28.
  30. Al-Dosari DI, Ahmed MM, Al-Rejaie SS, Alhomida AS, Ola MS. Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina. Nutrients 2017; 9:1161.
  31. Karaca T, Uz YH, Demirtas S, Karaboga I, Can G. Protective effect of royal jelly in 2, 4, 6 trinitrobenzene sulfonic acid-induced colitis in rats. Iran J Basic Med Sci 2015; 18:370.
  32. Xu J, Tam M, Samaei S, Lerouge S, Barralet J, Stevenson MM, et al. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis. Acta Biomater 2017; 48:247-257.
  33. Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, et al. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis 2006; 21:737-746.
  34. Romero M, Vera B, Galisteo M, Toral M, Gálvez J, Perez-Vizcaino F, et al. Protective vascular effects of quercitrin in acute TNBS-colitis in rats: role of nitric oxide. Food Funct 2017.
  35. Seto Y, Kato K, Tsukada R, Suzuki H, Kaneko Y, Kojo Y, et al. Protective effects of tranilast on experimental colitis in rats. Biomed Pharmacother 2017; 90:842-849.
  36. Suluvoy JK, Sakthivel K, Guruvayoorappan C. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines. Biomed Pharmacother 2017; 91:1113-1121.
  37. Prabhu V, Guruvayoorappan C. Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits. Int Immunopharmacol 2014; 18:124-134.
  38. Nürnberger W, Platonov A, Stannigel H, Beloborodov V, Michelmann I, Kries Rv, et al. Definition of a new score for severity of generalized Neisseria meningitidis infection. Eur J Pediatr 1995; 154:896-900.
  39. El-Ashmawy NE, Khedr NF, El-Bahrawy HA, El-Adawy SA. Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis. Inflammopharmacology 2017:1-9.
  40. Bezerra GB, de Souza LdM, dos Santos AS, de Almeida GKM, Souza MTS, Santos SL, et al. Hydroalcoholic extract of Brazilian red propolis exerts protective effects on acetic acid-induced ulcerative colitis in a rodent model. Biomed Pharmacother 2017; 85:687-696.
  41. Camacho-Barquero L, Villegas I, Sánchez-Calvo JM, Talero E, Sánchez-Fidalgo S, Motilva V, et al. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol. 2007; 7:333-342.
  42. Baykalir BG, Aksit D, Dogru MS, Yay AH, Aksit H, Seyrek K, et al. Lycopene Ameliorates Experi mental Colitis in Rats via Reducing Apoptosis and Oxidative Stress. Int J Vitam Nutr Res 2017; 1:9.
  43. Román ID, Cano-Martí­nez D, Lobo MVT, Fernández-Moreno MD, Hernández-Breijo B, Sacristán S, et al. Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease. Biomarkers 2017; 22:133-144.
  44. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140:1756-1767. e1751.
  45. Lv J, Zhang Y, Tian Z, Liu F, Shi Y, Liu Y, et al. Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-κВ activation. Int J Biol Macromol 2017; 98:723-729.
  46. Umehara Y, Kudo M, Nakaoka R, Kawasaki T, Shiomi M. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepatogastroenterology 2006; 53:879-882.
  47. Khan MN, Lane ME, McCarron PA, Tambuwala MM. Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function. Inflammopharmacology 2017:1-9.
  48. Jeon Y-D, Bang K-S, Shin M-K, Lee J-H, Chang Y-N, Jin J-S. Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis. BMC Complement Altern Med 2016; 16:459.
  49. Perkins N, Gilmore T. Good cop, bad cop: the different faces of NF-[kappa] B. Cell Death Differ 2006; 13:759.
  50. Ali AA, Al Haleem ENA, Khaleel SA-H, Sallam AS. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats. Pharmacol Rep 2017; 69:268-275.
  51. Raab Y, Hällgren R, Knutson L, Krog M, Gerdin B. A technique for segmental rectal and colonic perfusion in humans. Am J Gastroenterol 1992; 87.
  52. Hofseth LJ, Saito Si, Hussain SP, Espey MG, Miranda KM, Araki Y, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U S A 2003; 100:143-148.
  53. Kruidenier L, Kuiper I, van Duijn W, Mieremet"Ooms MA, van Hogezand RA, Lamers CB, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 2003; 201:17-27.
  54. Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA. Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Tohoku J Exp Med 2005; 206:131-139.
  55. Kannan N, Guruvayoorappan C. Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators. Int Immunopharmacol 2013; 16:57-66.
  56. Chaudhary G, Mahajan UB, Goyal SN, Ojha S, Patil CR, Subramanya SB. Protective effect of Lagerstroemia speciosa against dextran sulfate sodium induced ulcerative colitis in C57BL/6 mice. Am J Transl Res 2017; 9:1792.
  57. Zhou Y-H, Yu J-P, Liu Y-F, Teng X-J, Ming M, Lv P, et al. Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-α, NF-κBp65, IL-6) in TNBS-induced colitis in rats. Mediators Inflamm 2006; 2006.
  58. Coskun Z, Kerem M, Gurbuz N, Omeroglu S, Pasaoglu H, Demirtas C, et al. The study of biochemical and histopathological effects of spirulina in rats with TNBS-induced colitis. Bratisl Lek Listy 2011; 112:235-243.
  59. Yao J, Cao X, Zhang R, Li Y-x, Xu Z-l, Zhang D-g, et al. Protective effect of baicalin against experimental colitis via suppression of oxidant stress and apoptosis. Pharmacogn Mag 2016; 12:225.
  60. Colares JR, Schemitt EG, Hartmann RM, Moura RM, Morgan-Martins MI, Fillmann HS, et al. Effect of lecithin on oxidative stress in an experimental model of rats colitis induced by acetic acid. J coloproctol (rio j) 2016; 36:97-103.
  61. Bonnes-Taourel D, Guérin M-C, Torreilles J. Is malonaldehyde a valuable indicator of lipid peroxidation? Biochem Pharmacol 1992; 44:985-988.
  62. Xie Y, Guo Q, Li S, Liu M, Zhang Q, Xu Z, et al. Anti-inflammatory properties of Bifidobacterium longum expressing human manganese superoxide dismutase using the TNBS-induced rats model of colitis. J Microbiol Biotechnol 2017. DOI: 10.4014/jmb.1703.03044.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 947 Download : 484

Most read articles by the same author(s)